Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 24.5314.888.579.11-

What is the latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH is 24.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202524.53
Mar202414.88
Mar20238.57
Mar20229.11
Mar2021-

How is Price to Cash Earnings (PCE) of WINDLAS BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 24.53
64.85
Mar2024 14.88
73.63
Mar2023 8.57
-5.93
Mar2022 9.11
0
Mar2021 0 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,646.4 Cr 3.1% -6.3% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

3.1%

-6.3%

-28.4%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses